Calendario

  • December 2014

    1st December 2014: Deadline for early registration

  • January 2015

    31st January 2015: Deadline for Abstracts Submision

  • March 2015

    16th March 2015: Deadline to register before congress

  • March 2015

    23-25 March 2015: 4th European Expert Meeting on Rotavirus Vaccination (EEROVAC)

Últimas noticias


Socios estratégicos de SEC

Programme


EEROVAC TRAINING COURSE ON ROTAVIRUS
Monday 23 March
 

16.30 - 1830   EEROVAC TRAINING COURSE                   Federico Martinon-Torres
                                                                                               Timo Vesikari
                                                                                               Carlo Giaquinto
                                                                                               Hans-Iko Huppertz
                                                          
 4TH EEROVAC 

Monday 23 March

 
19.00   Opening ceremony and opening Remarks            Federico Martinón-Torres
 
19.15   Opening Lecture: The Continuing Rotavirus
            Vaccine Story                                                         Timo Vesikari
 
20.00   Tapas and drinks

Tuesday 24 March
 
Session I European Progress from Decision Making to Introduction
Chair: Carlo Giaquinto and Hans-Iko Huppertz
           
9.00     Introduction: The RV vaccination map of Europe        Carlo Giaquinto
9.10     ECDC analysis of the decision making process          Pier Luigi Lopalco
9.40     UK experience in introduction of universal
             RVimmunization                                                          Adam Finn
10.00   Germany - the road to STIKO recommendation          Hans-Iko Huppertz
             and afterwards
10.15   How France reversed its position                                 Pierre Pothier
 
10.30–11.00    Coffee break / Poster viewing
 
Session II Current RV vaccines
Chair: Pierre van Damme and Federico Martinón-Torres
 
11.00   Update on RotaTeq                                                       SP-MSD (TBA)
 
11.30   Update on Rotarix                                                          GSK (TBA)
 
12.00   Vaccine long term effectiveness in the US                     Daniel Payne
 
12.20   Vaccine effectiveness in Europe                                    Tessa Braeckman
 
12.40   ESPID/ESPGHAN Recommendations on
            rotavirus vaccination                                                       Pierre van Damme
 
13.00–14.30    Lunch and Poster viewing
 
 
Session III Effect of Rotavirus Vaccination
Chair: Timo Vesikari and Osamu Nakagomi
 
14.30   RV Serotypes before and after RV Vaccinations 
            in Europe                                                                          Miren Iturriza-Gómara
 
15.00   Effect of universal RV vaccination on VP7 and
            VP4 subtypes                                                                   Maria Hemming
 
15.20   Long-term shedding and formation of double
             reassortants                                                                     Timo Vesikari
 
15.40–16.00    Coffee break and Poster viewing
 
Session IV Adverse Effects
Chair: Roger Glass and Adam Finn
 
16.00   Intussusception experience from the US                        Umesh Parashar
16.20   Intussusception experience from Japan                         Toyoko Nakagomi
16.40   Intussusception experience from Europe                        Doris Oberle
17.00   Overall Discussion                            
 
Session V Best communications – Short oral presentations
Chair: Federico Martinón-Torres and Umesh Parashar
 
17.15-18.00
 
18.30   End of Day 1
 
21.30   Dinner

Wednesday 25 March
 
Session VI Rotavirus Vaccine Research
Chair: Osamu Nakagomi and Umesh Parashar
 
9.00     Indian live RV vaccines                                                Roges Glass
9.20     Chinese lamb reassortant rotavirus vaccine                Tai Guo
9.40     Non-live whole virus vaccine                                        Baoming Jiang
10.00   Non-live VP8 vaccine                                                   Xi Jiang
10.20   Non-live VP6 vaccine                                                   Vesna Blazevic
 
10.40–11.00    Break and poster viewing
 
 
Session VII Rotavirus Research
Chair: Harry Greenberg and Miren Iturriza-Gómara
 
11.00   Protective mechanism of RV infection                        James Crowe
11.30   Interferon and rotavirus                                               John Patton
12.00   Genetic determinants of RV pathogenicity                  Harry Greenberg
 
12.30   Closing Remarks                                                         Federico Martinón-Torres
 
            Lunch and Departures